Jim C. Gourdon - Concepedia

Author

Jim C. Gourdon

McGill University

Also Known As

J Gourdon, J. Gourdon, Jim C Gourdon, Jim C. Gourdon, Jim Gourdon

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

McGill University Université de Montréal Montreal Neurological Institute and Hospital McGill University Health Centre Centre Hospitalier de l’Université de Montréal

About

Jim C. Gourdon is an author at McGill University specializing in medicine, neuroscience, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	593
2	Social Sciences	11	13	646
3	Health Sciences	3	3	453
4	Public Health	3	3	112
5	Anesthesia	1	1	13

Jim C. Gourdon

Publications

Citations

H-Index

Page 1

	Year	Citations
Identification of multiple call categories within the rich repertoire of adult rat 50-kHz ultrasonic vocalizations: effects of amphetamine and social context Jennifer M. Wright, Jim C. Gourdon, Paul B. S. Clarke Psychopharmacology Social ContextPsychoacousticsBehavioral SciencesBioacousticsMultiple Call Categories	2010	349
COMPARATIVE EFFECTS OF HYPOTHYROIDISM, HYPERTHYROIDISM AND UNDERNUTRITION ON THE PROTEIN AND NUCLEIC ACID CONTENTS OF THE CEREBELLUM IN THE YOUNG RAT Jim C. Gourdon, J. Clos, Claude Coste, Journal of Neurochemistry Brain DevelopmentCell PopulationCell ProliferationParathyroid GlandThyroid Physiology	1973	71
The effect of age and length of gonadotropin stimulation on the in vitro embryo development of Holstein calf oocytes Luke Currin, Laura Michalovic, Anne‐Marie Bellefleur, Theriogenology Animal PhysiologyOocyteAnimal ReproductionTheriogenologyDevelopmental Biology	2017	51
The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset Adjia Hamadjida, Stephen G. Nuara, Nicolas Veyres, Psychopharmacology PsychiatryDopaminergic PsychosisPsychotropic MedicationPsychotic DisorderParkinsonian Marmoset	2017	45
The highly selective 5-HT2A antagonist EMD-281,014 reduces dyskinesia and psychosis in the l-DOPA-treated parkinsonian marmoset Adjia Hamadjida, Stephen G. Nuara, Dominique Bédard, Neuropharmacology Functional SelectivityMedicineL-dopa-treated Parkinsonian MarmosetPsychopharmacologyNeuropharmacology	2018	44
Interval of gonadotropin administration for in vitro embryo production from oocytes collected from Holstein calves between 2 and 6 months of age by repeated laparoscopy Hernán Baldassarre, Luke Currin, Laura Michalovic, Theriogenology OocyteAnimal ReproductionTheriogenologyDevelopmental BiologyFertility	2018	41
Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism Imane Frouni, Adjia Hamadjida, Cynthia Kwan, Neuropharmacology Functional SelectivityMedicineMglu2/3 ReceptorsNeurotransmitterExperimental Parkinsonism	2019	39
Endovascular procedures under near–real-time magnetic resonance imaging guidance: An experimental feasibility study Yves-Marie Dion, Hassen Ben El Kadi, Caroline Boudoux, Journal of Vascular Surgery Endovascular TechniqueMedical ImagingNear–real-time Magnetic ResonanceVascular SurgeryVascular Imaging	2000	33
The effect of mianserin on the severity of psychosis and dyskinesia in the parkinsonian marmoset Adjia Hamadjida, Stephen G. Nuara, Jim C. Gourdon, Progress in Neuro-Psychopharmacology and Biological Psychiatry Psychoactive DrugPsychiatryPsychotropic MedicationParkinsonian MarmosetPsychopharmacology	2017	32
Trazodone alleviates both dyskinesia and psychosis in the parkinsonian marmoset model of Parkinson’s disease Adjia Hamadjida, Stephen G. Nuara, Jim C. Gourdon, Journal of Neural Transmission PsychiatryParkinsonian Marmoset ModelMedicinePsychotropic MedicationParkinson ’	2017	31

Page 1